Research shows possible link between vaping and fatty liver disease

Los Angeles: Using electronic cigarettes may lead to accumulation of fat in the liver, a study on mice exposed to the devices suggests.

"The popularity of electronic cigarettes has been rapidly increasing in part because of advertisements that they are safer than conventional cigarettes," said Theodore C Friedman from Charles R Drew University of Medicine & Science in the US.

"But because extra fat in the liver is likely to be detrimental to health, we conclude that e-cigarettes are not as safe as they have been promoted to consumers," said Friedman, lead author of the study presented at the Endocrine Society's annual meeting in Chicago.

E-cigarettes contain nicotine, which Friedman and other researchers have reported is associated with non-alcohol fatty liver diseases.

However, the long-term effects of e-cigarettes on liver disease, diabetes, heart disease or stroke are unknown.

In the 12-week study, Friedman and colleagues studied mice missing the gene for apolipoprotein E, which makes them more prone to developing heart disease and fat in the liver.

All of the mice were fed a diet relatively high in fat and cholesterol.

One group of mice was put in a chamber that exposed them to e-cigarette aerosol, so that their blood nicotine levels were similar to that of smokers and e-cigarette users.

A second group of mice was exposed to saline aerosol.

The researchers collected liver samples, and looked at genes in the liver affected by e-cigarettes using a technique called RNA sequence analysis.

They found changes in 433 genes that were associated with fatty liver development and progression in the mice exposed to e-cigarettes.

The researchers also found that genes related to circadian rhythms (the body clock) were changed in mice exposed to e-cigarettes.

Circadian rhythm dysfunction is known to accelerate the development of liver disease including fatty liver diseases.